Delaware Chapter of the American College of CardiologyOur purpose is to contribute to the prevention of cardiovascular diseases, to ensure optimal quality of care for individuals with such diseases, and to foster the highest professional ethical standards. Please let us know what information you want to see here. Feel free to contact us with your ideas, needs and comments. |
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- Revascularization for Ischemic Ventricular DysfunctionThe goal of the REVIVED-BCIS2 trial was to evaluate percutaneous coronary intervention (PCI) plus optimal medical therapy compared with optimal medical therapy alone among individuals with left ventricular ejection fraction (LVEF) ≤35% and extensive coronary artery disease (CAD).
- CV Sports Chat: Dilated Aortas in Athletes"CV Sports Chat" is an interview series including expert discussions relative to sports and exercise cardiology and the health care management of athletes.
- Temporary Mechanical Circulatory Support in Infarct-Related CSWhat is the effect of early routine active percutaneous mechanical circulatory support (MCS) versus control treatment on 6-month all-cause mortality in patients with acute myocardial infarction-related cardiogenic shock (AMICS)?
- Anticoagulation in Device-Detected AF With or Without Vascular DiseaseWhat is the impact of concomitant vascular disease on the benefits and risks of anticoagulation for patients with device-detected atrial fibrillation (DDAF)?
- Semaglutide in HFpEF: Pooled Analysis of Four Randomized TrialsDoes semaglutide reduce risk for adverse cardiovascular (CV) events in patients with heart failure with preserved ejection fraction (HFpEF)?